News & Updates
Event Calendar
June 17, 2013 - 4:00pm
June 22, 2013 (All day)
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.
| Title | High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial. |
| Publication Type | Journal Article |
| Year of Publication | 2010 |
| Authors | Petri M, Brodsky RA, Jones RJ, Gladstone D, Fillius M, Magder LS |
| Journal | Arthritis and rheumatism |
| Volume | 62 |
| Issue | 5 |
| Pagination | 1487-93 |
| Date Published | 2010 May |
| Abstract | Monthly intravenous (IV) cyclophosphamide for 6 months has been the standard induction regimen for lupus nephritis, followed by a maintenance regimen of quarterly infusions for 2 years. We undertook this study to compare the efficacy and safety of the standard regimen versus a high-dose IV cyclophosphamide regimen. |
| DOI | 10.1177/0883073809350221 |
| Alternate Journal | Arthritis Rheum. |
Your Support is the Key
Help children like Matthew unlock their potential by becoming a Partner in Potential.
